skip to main content

Hybrid closed-loop insulin delivery — SCE Endocrinology MCQ

Instant feedback + full explanation. One question, done properly.

ModerateDiabetesHybrid closed-loop insulin deliverySCE Endocrinology

A 35-year-old woman with type 1 diabetes has HbA1c 58 mmol/mol and wants to reduce injection burden. She has good carbohydrate-counting skills and no recent DKA. She asks about closed-loop therapy. What is the most appropriate consideration?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: BAssess eligibility for hybrid closed-loop insulin delivery

Hybrid closed-loop therapy may be appropriate in selected adults with type 1 diabetes, particularly where glycaemic targets or hypoglycaemia burden justify it and the person can use the system safely. Basal insulin alone is unsafe in type 1 diabetes. Technology requires ongoing monitoring, education and troubleshooting.

Reference: NICE TA943; NICE NG17